Player FM - Internet Radio Done Right
Checked 28d ago
Aggiunto tre anni fa
Contenuto fornito da ReachMD. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da ReachMD o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !
Vai offline con l'app Player FM !
Repairing Macular Hole and Macular Pucker
Manage episode 327395090 series 3345006
Contenuto fornito da ReachMD. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da ReachMD o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Host: Roy Levit, MD
Guest: Allen Ho, MD
What are macular holes and macular pucker, and how do we treat these conditions? Host Dr. Roy Levit welcomes Dr. Allen Ho, professor of ophthalmology and an attending surgeon in the Retina Service at the Wills Eye Institute in Philadelphia, to discuss back-of-the-eye vitrectomy for the treatment of macular hole and macular pucker. Before this surgical procedure, we had no cure for these diagnoses.
…
continue reading
Guest: Allen Ho, MD
What are macular holes and macular pucker, and how do we treat these conditions? Host Dr. Roy Levit welcomes Dr. Allen Ho, professor of ophthalmology and an attending surgeon in the Retina Service at the Wills Eye Institute in Philadelphia, to discuss back-of-the-eye vitrectomy for the treatment of macular hole and macular pucker. Before this surgical procedure, we had no cure for these diagnoses.
49 episodi
Manage episode 327395090 series 3345006
Contenuto fornito da ReachMD. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da ReachMD o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Host: Roy Levit, MD
Guest: Allen Ho, MD
What are macular holes and macular pucker, and how do we treat these conditions? Host Dr. Roy Levit welcomes Dr. Allen Ho, professor of ophthalmology and an attending surgeon in the Retina Service at the Wills Eye Institute in Philadelphia, to discuss back-of-the-eye vitrectomy for the treatment of macular hole and macular pucker. Before this surgical procedure, we had no cure for these diagnoses.
…
continue reading
Guest: Allen Ho, MD
What are macular holes and macular pucker, and how do we treat these conditions? Host Dr. Roy Levit welcomes Dr. Allen Ho, professor of ophthalmology and an attending surgeon in the Retina Service at the Wills Eye Institute in Philadelphia, to discuss back-of-the-eye vitrectomy for the treatment of macular hole and macular pucker. Before this surgical procedure, we had no cure for these diagnoses.
49 episodi
Tutti gli episodi
×Host: Jennifer I. Lim, MD, FARVO Guest: Carl Regillo, MD What evidence do we have that blocking Ang-2 and VEGF-A is beneficial for patients? Tune in to hear Dr. Jennifer Lim and Dr. Carl Regillo examine the anatomical and biomarker evidence surrounding dual inhibition of Ang-2 and VEGF-A. Find out how bispecific targeting can benefit patients with neovascular age-related macular degeneration and diabetic macular edema.…
Host: Carl Regillo, MD Guest: Jennifer I. Lim, MD, FARVO What are the biomarkers that indicate dual targeting helps to reduce vascular leakage and suppress neovascularization? Join Dr. Carl Regillo and Dr. Jennifer Lim as they discuss the biomarkers of Ang-2 and VEGF-A suppression. Hear how to achieve earlier and faster fluid resolution in both neovascular age-related macular degeneration and diabetic macular edema.…
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Arghavan Almony, MD The production of biosimilar therapies is setting the stage for a shift in how we approach treating patients with wet AMD, diabetic retinopathy, macular edema, and other retinal diseases, but many questions remain regarding how their efficacy and safety compare to the reference products and how we can best talk to our patients about these treatment options. To help shed light on these and other FAQs, Dr. Mary Katherine Cheeley speaks with Dr. Arghavan Almony, Adjunct Assistant Professor at Wallace School of Osteopathic Medicine at Campbell University in North Carolina.…
Host: Jennifer Caudle, DO Guest: Anne Negrin, MD Since eye issues are becoming increasingly common in patients with rheumatological conditions, it’s now more vital than ever that physicians are aware of their common symptoms. Joining Dr. Jennifer Caudle is Dr. Anne Negrin, an ophthalmologist in New York, to break down these symptoms and to focus on rheumatological concerns that ophthalmologists see in practice.…
Host: Jennifer Caudle, DO Guest: Jean Bennett, MD, PhD Guest: Albert Maguire, MD Power couple Drs. Jean Bennett and Albert Maguire discuss how their new therapy for the RPE65 gene, which causes retinal blindness, was recently approved by the FDA to become the first gene therapy treatment for a genetic disease in the United States and the first worldwide treatment for inherited blindness. Not only do they delve into the mechanics of the corrected gene injection, but they also explain what this milestone means for patient eligibility and how their marriage has played a role in the success of their research partnership. Dr. Jean Bennett is the F.M. Kirby Professor of Ophthalmology at the Perelman School of Medicine at the University of Pennsylvania, and Dr. Albert Maguire is a Professor of Ophthalmology at the Hospital of the University of Pennsylvania and Attending Physician in the Division of Pediatric Ophthalmology at Children’s Hospital of Philadelphia.…
[Read the Article] Proliferative diabetic retinopathy (PDR) is a leading cause of vision loss in patients with diabetes, resulting in up to 24,000 cases of blindness each year in the United States. Laser therapy has been the most common treatment used to help reduce severe vision loss, but the procedure has many side effects including permanent loss of peripheral vision and swelling of the retina.A group of researchers from across the US tested an alternative treatment using an injectable medication called ranibizumab, to see if it would be as effective as the laser therapy. They studied more than 300 patients with PDR, assigning them to either receive standard laser therapy or an injection into the eye. In total, they treated close to 400 eyes.Outcomes, especially loss of vision, were compared at two years. Over the two year period, researchers found that patients receiving the injections of medication had fewer side effects and did somewhat better in terms of vision loss than those who received laser therapy. [Watch more videos of The JAMA Report]…
Host: Jennifer Caudle, DO Dr. Jennifer Caudle welcomes Dr. Patrick Spencer, Chairman of the Department of Ophthalmology at Grandview Medical Center in Dayton, Ohio. Their discussion centers on primary care manifestations of sickle cell retinopathy, from early to late-stage presentations and the gold standard treatment approaches along this disease course.…
Host: Brian P. McDonough, MD, FAAFP Dr. Brian McDonough welcomes Dr. Gail L. Torkildsen, staff ophthalmologist at Andover Eye Associates and one of the leading Dry Eye Principal Investigators in the world. Dr. Torkildsen has served as P.I. on over 20 client-sponsored Dry Eye studies since 2002. In this discussion she takes listeners on a tour of common eye problems faced in primary care, and how clinicians can better prepare themselves to address issues such as Meibobian gland disorders, blepharitis, dry eyes, and conjunctivitis with greater confidence.…
Host: Brian P. McDonough, MD, FAAFP A clinical pearl in the arena of eye care is that serious eye problems tend to manifest serious symptoms and signs, which makes vision loss one of the key findings in a diagnostic workup. Yet vision testing is commonly neglected in primary care practice even when patients present with eye-related complaints. What are the most important steps a clinician can take when assessing eye problems, and where does the primary care practitioner fit into the ophthalmologic care continuum? Dr. Brian McDonough welcomes Dr. Sumitra Khandelwal, Assistant Professor of Ophthalmology at Baylor College of Medicine, to examine the top issues in eye care for generalists and ophthalmic specialists.…
Host: Brian P. McDonough, MD, FAAFP On average, more than 90% of adults spend more than two hours each day using a digital device, and for 60% of the population, that daily use pattern extends beyond five hours. Regardless of the reasons why, all that time can take a toll on the eyes and lead to digital eye strain. Speaking on the health implications of digital eye strain is Dr. Dora Adamopolous, optometrist in practice in Alexandia, VA.…
Guest: Stephen Orlin, MD This Excerpt from the Podium comes from Prova Education's "From Guidelines to Practice" program in New York City and features Dr. Stephen Orlin, Associate Professor of Ophthalmology at the University of Pennsylvania School of Medicine. Dr. Orlin speaks on the various types of conjunctivitis, their common etiologies, and their respective management approaches.…
Guest: Stephen Orlin, MD This Excerpt from the Podium features Dr. Stephen Orlin, Associate Professor of Ophthalmology at the University of Pennsylvania School of Medicine, speaking on the patient workup for red eye at Prova Education's "From Guidelines to Practice" program in New York City.
Guest: Stephen Orlin, MD The classic "red eye" presentation by your patient may be a common sighting in your clinical practice, but are you truly up to date on the various causes, treatments, and pitfalls that clinicians encounter when confronting ocular problems? Discussing this issue is Dr. Stephen Orlin, Associate Professor of Ophthalmology, Director of the Cornea Department, and Co-Director of the Refractive Surgery Service at the University of Pennsylvania.…
Host: Lee Freedman, MD Guest: Jean Bennett, MD, PhD Host Dr. Lee Freedman and Dr. Jean Bennett, the FM Kirby Professor of Epistemology at the University of Pennsylvania School of Medicine, explore how the study of molecular genetics of inherited retinal degenerations can help develop treatments for congenital eye disorders, as well as adult-onset diseases and possibly disorders that affect the body outside the eye.…
Host: Steven Edelman, MD Guest: Azza El-Remessy, PhD, RPh Retinopathy is one of the most common complications for patients living with diabetes but there are few treatment options and no early-stage interventions. How is research helping to pinpoint potential targets for early intervention and a possible oral treatment? Join host Dr. Steven Edelman and his guest, assistant professor and director of clinical and experimental therapeutics at the University of Georgia, Dr. Azza El-Remessy, as they discuss the latest research into the potential of statins to prevent diabetic-related blindness.…
Benvenuto su Player FM!
Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.